LABT
Lakewood-Amedex Biotherapeutics Inc.Company with tickers: LABT
CIK
2079272
CUSIP
51255A102
Shares Outstanding
14,018,673
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | $886,750 | USD | 2026-03-31 | 10-Q | 2026-05-22 |
| Research & Development | $182,147 | USD | 2026-03-31 | 10-Q | 2026-05-22 |
| Operating Income | $-886,750 | USD | 2026-03-31 | 10-Q | 2026-05-22 |
| Net Income | $-923,291 | USD | 2026-03-31 | 10-Q | 2026-05-22 |
| EPS (Basic) | $-0.20 | USD/shares | 2026-03-31 | 10-Q | 2026-05-22 |
| EPS (Diluted) | $-0.20 | USD/shares | 2026-03-31 | 10-Q | 2026-05-22 |